Health and Healthcare
Health and Healthcare Articles
Pharmacy and health insurer CVS handily beat expected earnings and revenue estimates for the second quarter.
Published:
Regeneron Pharmaceuticals, one of the front-runners for the development of a COVID-19 treatment, released an update on its antibody drug combination on Monday.
Published:
Alterity Therapeutics stock more than doubled on Tuesday after the company announced new data for its lead drug candidate for the treatment of multiple system atrophy.
Published:
Amarin reported its latest quarterly results on Tuesday morning and gave an update on the most recent developments with its blockbuster drug Vascepa.
Published:
All those investors who were buying into the hype that Kodak will be a major player in making materials for generic drugs with a big government loan are being reminded just how chasing news pops in...
Published:
CymaBay Therapeutics posted a huge gain to start off the week after the company reported results from a late-stage clinical study for the treatment of primary biliary cholangitis.
Published:
GW Pharmaceuticals shares popped early on Monday morning after the company announced that it received a key approval from the FDA for Epidiolex to treat certain seizures.
Published:
Over the past few days, more than 1,000 people have died from COVID-19 per day in the United States. At the current pace, the disease will kill 200,000 people by Labor Day, a figure hard to imagine a...
Published:
When Merck & Co. (NYSE: MRK) reported its second-quarter financial results before the markets opened on Wednesday, the pharmaceutical giant said that it had earnings per share (EPS) of $1.37 and...
Published:
Whether it’s all speculation or day trading, it seems there is no end to seeing major gains in small and micro-cap stocks that have positive announcements around anything to do with testing,...
Published:
Investors have flocked to the dividends of Big Pharma and flocked to the limitless upside of major biotech outfits for years. Valuations are no longer considered high for these two healthcare...
Published:
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United States and Belgium.
Published:
Edesa Biotech joins the list of COVID-19 stocks, as the company is making headway with regulatory agencies for its late-stage study. Investors were quick to give this firm the coronavirus bump, more...
Published:
Health care officials have said that masks and social distancing are the keys to arresting the spread of COVID-19. Yet, schools in some rural areas will open without insisting on these safety...
Published:
Eastman Kodak is making a fresh move to manufacturing drug ingredients with a $765 million government loan under the direction of President Trump.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.